Locations · Efringen-Kirchen · Headquarters in the tri-border area

On Basel's doorstep.

Name: A&O Pharma GmbH Efringen-Kirchen
Address: Am Sattel 17, Efringen-Kirchen, Baden-Württemberg, 79588, DE
Telephone: +49 7628 95 03 119

From our headquarters in Efringen-Kirchen, Qualified Persons release medicinal products for the EU market under our own manufacturing and import authorisation. Regulatory affairs and consulting are based here too, a few kilometres from Basel.

Book an initial consultation Batch release and import

47.66° N · 7.56° E

Qualified Persons on site

named experts on site

Our own

manufacturing and import authorisation

about 11 km

to Basel as the crow flies

Batch release and import

EU batch release and import from one provider.

No Qualified Person of your own, or importing medicinal products into the EU from a third country? We review GMP-compliant manufacture, and our Qualified Persons under § 14 AMG certify your batches for release in the EEA. Import runs under our own manufacturing and import authorisation, with regulatory affairs and GMP consulting available alongside.

The route from Switzerland is especially short: Basel is about eleven kilometres away. And because the EU and Switzerland mutually recognise their GMP controls, products covered by the agreement do not need to be retested in the EU.

01 Batch release by a named Qualified Person
02 Import from third countries under our manufacturing and import authorisation
03 Regulatory affairs and marketing authorisation from the same team
04 GMP consulting and operational QA tasks, if you would like to hand them over

Case studies QP batch release after EU import for a Swiss contract manufacturer Mid-sized contract manufacturer of medicinal products Read the case study

Two sites on the border

Efringen-Kirchen today, Lörrach from 2027.

Efringen-Kirchen is about eleven kilometres from Basel as the crow flies. In Lörrach, about eight kilometres from Basel, we are setting up our third site: packaging and labelling, storage and distribution, and batch release under our own manufacturing authorisation, expected from the end of the first quarter of 2027.

Our third site is Itzehoe in Schleswig-Holstein, home to our GMP-certified laboratory. All three sites work as one team, reachable on one phone number.